Most Read stock photos

[DIGEST: Business Insider, Gizmodo, Washington Post, Wall Street Journal, Ars Technica, Time]

Drug manufacturer Mallinckrodt Pharmaceuticals has settled a lawsuit with the US Federal Trade Commission (FTC) for creating a monopoly over a life-saving medication for infants with epilepsy — and then increasing the price by 85,000 percent.

Keep reading... Show less